CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-31 | Burke Steven Keith SVP, Chief Medical Officer | Sale | −1,147 | $0.36 | $416 | 418,016 |
| 2022-06-08 | Spellman David A SVP, CFO and Treasurer | Grant or award | +200,000 | 328,599 | ||
| 2022-06-08 | Spellman David A SVP, CFO and Treasurer | Grant or award · Stock Option (Right to buy) | +200,000 | 200,000 | ||
| 2022-06-08 | ZUMWALT LEANNE M Director | Grant or award | +13,700 | 13,700 | ||
| 2022-06-08 | ZUMWALT LEANNE M Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2022-06-08 | Wolf Myles Director | Grant or award | +13,700 | 37,681 | ||
| 2022-06-08 | Wolf Myles Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2022-06-08 | Smith Cynthia Director | Grant or award | +13,700 | 65,233 | ||
| 2022-06-08 | Smith Cynthia Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2022-06-08 | ROGERS MICHAEL W Director | Grant or award | +13,700 | 66,029 | ||
| 2022-06-08 | ROGERS MICHAEL W Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2022-06-08 | GILMAN STEVEN C Director | Grant or award | +13,700 | 57,130 | ||
| 2022-06-08 | GILMAN STEVEN C Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2022-06-08 | FRIESON RON Director | Grant or award | +13,700 | 13,700 | ||
| 2022-06-08 | FRIESON RON Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2022-06-08 | ADAMS ADRIAN Director | Grant or award | +13,700 | 104,800 | ||
| 2022-06-08 | ADAMS ADRIAN Director | Grant or award · Stock Option (Right to buy) | +20,100 | 20,100 | ||
| 2022-06-03 | GILMAN STEVEN C Director | Sale | −4,567 | $0.36 | $2K | 43,430 |
| 2022-05-12 | Burke Steven Keith SVP, Chief Medical Officer | Grant or award | +200,000 | 417,663 | ||
| 2022-05-12 | Burke Steven Keith SVP, Chief Medical Officer | Grant or award · Stock Option (Right to buy) | +200,000 | 200,000 |
Page 10 of 21 · 405 trades